
    
      This study broadly consists of two phases: screening / washout phase (5-7 day) followed by
      treatment phase (approximately of 8 weeks). Participants will be asked to return to the study
      site 1 week, 4 weeks and 8 weeks after their randomisation visit for instrumental
      measurements and clinical assessments.
    
  